TNF and pneumonia: Cellulitis (n = 25) and pneumonia (n = 24) were the most commonly reported SIs among all patients, with the most cases of cellulitis (n = 22) and pneumonia (n = 17) both reported in the TNF inhibitors cohort (Table 5).